Dr. Bradley M. Wertheim

Dr. Wertheim is a member of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital.  He specializes in the care of patients with pulmonary arterial hypertension (PAH) and complex heart-lung interactions.  After studying biochemistry at Lafayette College, Dr. Wertheim received his Doctorate in Medicine from Harvard Medical School in 2011.  At the Massachusetts General Hospital, he completed his residency in internal medicine in 2014.   Dr. Wertheim then trained in pulmonary and critical care medicine at Brigham and Women’s Hospital, and he graduated in 2017.  During this time, he was the first physician selected for the Burke Advanced Fellowship in Pulmonary Heart Disease, one of the few dedicated pulmonary hypertension training programs in the country.    His clinical interests include pulmonary hypertension, pulmonary embolism, critical care medicine, unexplained dyspnea, and cardiopulmonary exercise testing.  He founded the Rheumatic Pulmonary Vascular Disease Clinic to promptly diagnose pulmonary hypertension in patients with connective tissue diseases such as systemic sclerosis.  In 2021-2022, Dr. Wertheim’s patient satisfaction scores ranked in the top 10% of physician nationwide.  He is board-certified in pulmonary disease, critical care medicine, and internal medicine.  As a scientist, Dr. Wertheim studies the biology of pulmonary arterial hypertension to identify treatment strategies.  He earned research awards from the Pulmonary Vascular Research Institute and Brigham and Women’s Hospital/Hearst Foundation.  He receives funding from the National Heart Lung and Blood Institute/National Institutes of Health.  A list of his publications can be found here.A member of the Harvard Medical School faculty, Dr. Wertheim trains fellows and residents in his clinic and inpatient practice at Brigham and Women’s Hospital.  Outside of medicine, he enjoys time with his wife and daughters, saltwater fishing, boating, working with tools, and enjoying the outdoors.

Dr. Wertheim is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Lung Metastases.

His clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Pulmonary Hypertension.